Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | ASND | EXEL | ||
| Company | Intra-Cellular Ther | Ascendis Pharma ADR | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 131.90 | 254.40 | 56.07 | ||
| High | 131.98 | 258.86 | 56.34 | ||
| Low | 131.63 | 251.99 | 55.11 | ||
| Latest | 131.87 | 253.86 | 55.37 | ||
| Change | -0.05 | +1.20 | -0.28 | ||
| % Change | -0.04% | +0.47% | -0.50% | ||
| Volume | 16,062,900 | 390,300 | 1,838,000 | ||
| 20-Day Average Volume | 2,474,570 | 756,720 | 2,540,015 | ||
| Previous Close | 131.92 | 252.66 | 55.65 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 263.85 | 55.61 | ||
| 20-Day Raw Stochastic | 86.25% | 12.03% | 51.06% | ||
| 20-Day Relative Strength | 82.75 | 51.93 | 56.31 | ||
| Weighted Alpha | +83.21 | +45.91 | +33.27 | ||
| Today's Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 64% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | -2.74% since 07/17/26 | -0.98% since 07/17/26 | ||
| Low | 131.63 on 04/01/25 | 249.99 on 07/23/26 | 54.20 on 07/23/26 | ||
| High | 131.98 on 04/01/25 | 263.26 on 07/20/26 | 56.69 on 07/20/26 | ||
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | +6.66% since 06/24/26 | +4.73% since 06/24/26 | ||
| Low | 131.18 on 03/05/25 | 235.51 on 06/25/26 | 51.77 on 06/25/26 | ||
| High | 131.98 on 04/01/25 | 282.15 on 07/09/26 | 57.57 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | +10.73% since 04/24/26 | +23.21% since 04/24/26 | ||
| Low | 80.82 on 01/07/25 | 203.80 on 06/08/26 | 43.50 on 05/04/26 | ||
| High | 131.98 on 04/01/25 | 282.15 on 07/09/26 | 57.57 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | +7.85% since 01/23/26 | +25.07% since 01/23/26 | ||
| Low | 70.90 on 10/07/24 | 203.80 on 06/08/26 | 39.71 on 03/02/26 | ||
| High | 131.98 on 04/01/25 | 282.15 on 07/09/26 | 57.57 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 15,835,022 | 13,917,526 | ||
| Shares Outstanding, K | 106,522 | 62,377 | 251,355 | ||
| Annual Sales | 680,850,000 | 814,760,000 | 2,320,130,000 | ||
| Annual Net Income | -74,680,000 | -258,000,000 | 782,570,000 | ||
| Last Quarter Sales | 199,220,000 | 288,620,000 | 610,810,000 | ||
| Last Quarter Net Income | -16,890,000 | 736,580,000 | 210,470,000 | ||
| 60-Month Beta | 0.46 | 0.37 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | 0.32 on 05/07/26 | 0.87 on 05/05/26 | ||
| Earnings Date | 05/06/25 | 08/06/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 18.61 | ||